- Home
- NLSP vs TSVT Comparison
NLSP vs TSVT Comparison
Compare NLSP & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- TSVT
- Stock Information
- Founded
- NLSP 2015
- TSVT 2021
- Country
- NLSP Switzerland
- TSVT United States
- Employees
- NLSP N/A
- TSVT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- NLSP Health Care
- TSVT Health Care
- Exchange
- NLSP Nasdaq
- TSVT Nasdaq
- Market Cap
- NLSP 243.8M
- TSVT 253.9M
- IPO Year
- NLSP 2021
- TSVT N/A
- Fundamental
- Price
- NLSP $5.28
- TSVT $4.74
- Analyst Decision
- NLSP
- TSVT Buy
- Analyst Count
- NLSP 0
- TSVT 6
- Target Price
- NLSP N/A
- TSVT $10.40
- AVG Volume (30 Days)
- NLSP 26.9K
- TSVT 343.8K
- Earning Date
- NLSP 10-18-2024
- TSVT 11-12-2024
- Dividend Yield
- NLSP N/A
- TSVT N/A
- EPS Growth
- NLSP N/A
- TSVT N/A
- EPS
- NLSP N/A
- TSVT N/A
- Revenue
- NLSP N/A
- TSVT $44,120,000.00
- Revenue This Year
- NLSP N/A
- TSVT N/A
- Revenue Next Year
- NLSP N/A
- TSVT $22.42
- P/E Ratio
- NLSP N/A
- TSVT N/A
- Revenue Growth
- NLSP N/A
- TSVT N/A
- 52 Week Low
- NLSP $4.08
- TSVT $1.54
- 52 Week High
- NLSP $40.60
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- NLSP 45.46
- TSVT 51.27
- Support Level
- NLSP $4.72
- TSVT $4.60
- Resistance Level
- NLSP $5.50
- TSVT $4.92
- Average True Range (ATR)
- NLSP 0.64
- TSVT 0.34
- MACD
- NLSP 0.05
- TSVT -0.01
- Stochastic Oscillator
- NLSP 41.67
- TSVT 51.96
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.